112 related articles for article (PubMed ID: 15015624)
1. Yearly alterations in prognostic factors in gastric cancer during the post-operative period.
Kunisaki C; Shimada H; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H
Anticancer Res; 2004; 24(1):377-83. PubMed ID: 15015624
[TBL] [Abstract][Full Text] [Related]
2. Significance of long-term follow-up of early gastric cancer.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono H; Nagahori Y; Hosoi H; Takahashi M; Kito F; Shimada H
Ann Surg Oncol; 2006 Mar; 13(3):363-9. PubMed ID: 16485155
[TBL] [Abstract][Full Text] [Related]
3. Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature.
Aurello P; D'Angelo F; Rossi S; Bellagamba R; Cicchini C; Nigri G; Ercolani G; De Angelis R; Ramacciato G
Am Surg; 2007 Apr; 73(4):359-66. PubMed ID: 17439029
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer.
Saito H; Fukumoto Y; Osaki T; Yamada Y; Fukuda K; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2008 Feb; 97(2):132-5. PubMed ID: 17979134
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic strategy for patients with pN0 gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
J Surg Oncol; 2006 Sep; 94(3):212-9. PubMed ID: 16900514
[TBL] [Abstract][Full Text] [Related]
6. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
7. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcome of serosa-negative advanced gastric carcinoma.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Anticancer Res; 2004; 24(5B):3169-75. PubMed ID: 15510607
[TBL] [Abstract][Full Text] [Related]
9. Association of the number of metastatic perigastric lymph nodes with long-term survival in gastric cancer.
Chikara K; Hiroshi S; Masato N; Goro M; Yuichi O; Hidetaka O; Hirotoshi A
Hepatogastroenterology; 2005; 52(61):277-80. PubMed ID: 15783049
[TBL] [Abstract][Full Text] [Related]
10. [The value of metastatic lymph nodes ratio in predicting the prognosis of patients with T3 gastric carcinoma].
Yu JX; Wu YL; Yang LT
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):922-5. PubMed ID: 16029534
[TBL] [Abstract][Full Text] [Related]
11. Recurrence after curative resection of early gastric cancer.
Youn HG; An JY; Choi MG; Noh JH; Sohn TS; Kim S
Ann Surg Oncol; 2010 Feb; 17(2):448-54. PubMed ID: 19904573
[TBL] [Abstract][Full Text] [Related]
12. Predictors of long-term survival in pN3 gastric cancer patients.
Kim J; Cheong JH; Hyung WJ; Shen J; Choi SH; Noh SH
J Surg Oncol; 2004 Oct; 88(1):9-13. PubMed ID: 15384089
[TBL] [Abstract][Full Text] [Related]
13. [Relationship between metastatic rate and amount of lymph nodes and prognosis of gastric cancer].
Li K; Xu HM; Chen JQ
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2113-6. PubMed ID: 16313820
[TBL] [Abstract][Full Text] [Related]
14. Surgical results of early gastric cancer and proposing a treatment strategy.
Lo SS; Wu CW; Chen JH; Li AF; Hsieh MC; Shen KH; Lin HJ; Lui WY
Ann Surg Oncol; 2007 Feb; 14(2):340-7. PubMed ID: 17094028
[TBL] [Abstract][Full Text] [Related]
15. Multivariate prognostic study on large gastric cancer.
Shiraishi N; Sato K; Yasuda K; Inomata M; Kitano S
J Surg Oncol; 2007 Jul; 96(1):14-8. PubMed ID: 17582596
[TBL] [Abstract][Full Text] [Related]
16. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes.
Xu DZ; Geng QR; Long ZJ; Zhan YQ; Li W; Zhou ZW; Chen YB; Sun XW; Chen G; Liu Q
Ann Surg Oncol; 2009 Feb; 16(2):319-26. PubMed ID: 19050970
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinical evaluation of patients with T2 gastric cancer.
Komatsu S; Ichikawa D; Kurioka H; Kan K; Shioaki Y; Ueshima Y; Hamashima T; Lee CJ; Ikeda E; Ueda Y; Otsuji E; Oka T; Yamagishi H
Hepatogastroenterology; 2005; 52(63):965-8. PubMed ID: 15966242
[TBL] [Abstract][Full Text] [Related]
18. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
19. Tumor diameter as a prognostic factor in patients with gastric cancer.
Kunisaki C; Makino H; Takagawa R; Oshima T; Nagano Y; Kosaka T; Ono HA; Otsuka Y; Akiyama H; Ichikawa Y; Shimada H
Ann Surg Oncol; 2008 Jul; 15(7):1959-67. PubMed ID: 18369676
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of metastatic lymph node ratio in advanced gastric cancer.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Anticancer Res; 2005; 25(2B):1369-75. PubMed ID: 15865093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
